The COVID-19 pandemic has embarked upon the importance of point of care solutions and to improve the scenario of Healthcare system. Many low to middle income countries across the globe are troubled with various communicable, infection, and life-threatening diseases, that are preventable and curable if detected early and accurately.
With poor health infrastructure and lack of proper healthcare set up and diagnostic instruments & kits at the point of patient contact and disruption in immersion lead to progression and spread of the disease causes a big threat to the patient health, and even on the society and also on the country’s economy.
Here comes the importance of early point of care tests and diagnosis. The ongoing COVID-19 pandemic and the rapid mutation in the viral strains has created a huge gap in the healthcare system and has also highlighted the importance of hygiene, social distancing, good health, and the most important the need for rapid and accurate diagnosis.
The urban center healthcare is catering to the needs of a small segment of the population, but the majority of the residents in rural or poor areas are still struggling with limited access to timely disease diagnosis. For global diseases elimination, it is important to enable ubiquitous access of proper and immediate point of care with high quality diagnostic for all following a decentralized method, and present novel care solutions immediately to the patient that are in need.
Point Of Care testing defines the ability to conduct proper and reliable diagnostic tests even there is an absence of proper laboratory and healthcare setup or infrastructure. These tests must be user-friendly, cost effective, rapid, portable, battery operated, and must have excellent data transfer capability. They can significantly reduce the turnaround time with proper intervention, even in remote locations or resource-limited settings, and the treatment or tests must be completed within the same day. So, the early diagnosis can help detect the root cause of the concern and early treatment ensures quick patient recovery and also helps reduce the spread of infections disease to the community. If there is an early and proper management of the diseases and if they are control in the initial stages, it also solves the problems of people living in remote or inaccessible areas by providing them with remote healthcare access.
Trivitron Healthcare has pioneered in molecular testing and point of care diagnosis by offering antigen testing kits, for all laboratories, primary centers, hospitals and essentially can work for all levels of healthcare, thereby creating access to a molecular diagnostic for people of all areas.
With the increasing demand for assays of infectious diseases, the diagnostic assays can help in early and accurate diagnosis and with the start of initial treatment right at the first point of care. With proven abilities to work with primary healthcare centers, this technology can help manage the global fight in control and management of several infectious diseases.